Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Thursday 18 November 2021 3:38 pm  |  Updated:  Thursday 18 November 2021 3:31 pm

German disease control head warns of ‘terrible Christmas’ as hospitals reach breaking point

By: Michiel Willems

Add as a preferred source on Google
Berlin's skyline (Getty)

The head of Germany’s disease control agency has warned the country faces a “really terrible Christmas” amid news that overrun hospitals are sending patients abroad.

German politicians are debating measures that would replace the nationwide epidemic rules, which will expire at the end of the month. It comes as the country’s hospitals face an overwhelming fourth wave with two patients today sent across the border to Italy for care.

The Robert Koch Institute, Germany’s disease control agency, said on Thursday that 65,371 newly confirmed cases had been reported in a single day, continuing the upward trend that experts have been warning about for weeks.

“We are currently heading towards a serious emergency,” said the agency’s director, Lothar Wieler. “We are going to have a really terrible Christmas if we don’t take counter-measures now.”

Wieler said Germany needs to increase its vaccination rates to significantly above 75 per cent, from 67.7 per cent at present.

Some regions in Germany have vaccination rates as low as 57.6%.

He also called for the closure of clubs and bars, an end to large-scale events and access to many parts of public life to be limited to those with vaccine or recovery certificates.

Wieler warned that hospitals across Germany are struggling to find beds for Covid-19 patients and those with other illnesses.

Read more

Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • The former African gold miner taking on the billionaire Issa brothers

  • Music tycoon Simon Cowell sued by prominent City lawyer

  • As it happened: Choppy day for FTSE 100 after Iran closes Strait of Hormuz as strikes ramp up

  • Barclays and Lloyds back calls to digitalise UK markets and unlock £33bn boost

More from City PM

  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Mosaic Clinical Technologies™ Launches Mosaic Reporting™, an AI-Native Reporting Platform Built for Radiology Workflows

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook